DJIA 18,077.28 -2.86 -0.02%
NASDAQ 5,075.60 -16.49 -0.32%
S&P 500 2,115.03 -2.66 -0.13%
market minute promo

AbbVie Inc. (NYSE: ABBV)

65.30 -0.77 (-1.17%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ABBV $65.30 -1.17%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $66.02
Previous Close $66.07
Daily Range $65.20 - $66.66
52-Week Range $48.95 - $70.76
Market Cap $104.1B
P/E Ratio 49.68
Dividend (Yield) $2.04 (3.1%)
Ex-Dividend Date
Dividend Pay Date
Volume 8,490,919
Average Daily Volume 11,523,946
Current FY EPS $4.20



AbbVie Inc. (ABBV) Description

AbbVie Inc. Website:

News & Commentary

Can You Guess Which State Won't Pay for Hepatitis C Drugs?

One state decided to take a hard line stance against Gilead's pricey hep C drugs last year. And this decision may end up turning into a huge windfall for AbbVie's rival therapy. Here's why.

Learning From The Masters: Q&A Session With Buyandhold 2012

3 'Safe' Biotech Picks

I Called It: What's The Take Home Message?

Trusty Horses; Tools, Pizza and Shoes: Jim Cramer's Best Blogs

Astra Deals Add To Ballooning Up-Front Payments

Are Biosimilars the Next Big Thing in Biotech?

Biosimilars could soon become a major force in biotech as multiple top-selling biologics lose patent protection. So are biosimilars the next big thing in biotech, or are they overhyped?

Merck Reports Encouraging Data on HCV Combo Candidate - Analyst Blog

AbbVie's HCV Cocktail Treatment Under FDA Priority Review - Analyst Blog

AbbVie Focusing On Diversification Routes To Put Higher Sales Numbers On The Board

See More ABBV News...